NDC 17856-1127-01 - OneLAX SENNA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1127
- Requested NDC
- 17856-1127-01
- Package NDCs from labels
- 17856-1127-5, 17856-1127-1, 17856-1127-6, 17856-1127-2, 17856-1127-7, 17856-1127-3, 17856-1127-8, 17856-1127-4, 17856-1127-9, 17856-1127-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-12-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OneLAX SENNA SYRUP Natural Vegitable Lexative Natural Choclate Flavor | ATLANTIC BIOLOGICALS CORP. | 2025-12-29 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1127-1 | OneLAX SENNA | 120 in 1 BOX, UNIT-DOSE | SYRUP | 120 | 4 | |
| 17856-1127-2 | OneLAX SENNA | 72 in 1 BOX, UNIT-DOSE | SYRUP | 72 | 4 | |
| 17856-1127-3 | OneLAX SENNA | 72 in 1 BOX, UNIT-DOSE | SYRUP | 72 | 4 | |
| 17856-1127-4 | OneLAX SENNA | 72 in 1 BOX, UNIT-DOSE | SYRUP | 72 | 4 | |
| 17856-1127-5 | OneLAX SENNA | 2.5 mL in 1 SYRINGE | SYRUP | 2.5 | 4 | |
| 17856-1127-6 | OneLAX SENNA | 5 mL in 1 CUP, UNIT-DOSE | SYRUP | 5 | 4 | |
| 17856-1127-7 | OneLAX SENNA | 10 mL in 1 CUP, UNIT-DOSE | SYRUP | 10 | 4 | |
| 17856-1127-8 | OneLAX SENNA | 15 mL in 1 CUP, UNIT-DOSE | SYRUP | 15 | 4 | |
| 17856-1127-9 | OneLAX SENNA | 120 in 1 BOX, UNIT-DOSE | SYRUP | 120 | 4 | |
| 17856-1127-9 | OneLAX SENNA | 2.5 mL in 1 SYRINGE | SYRUP | 2.5 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1127 | ONELAX SENNA (SENNA) SYRUP [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, 10 package rows | 20250525_d2a5a13a-e7e4-488a-b60b-4dd467efa971.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1127-1 | ML - Milliliter | 17856-1127 | c08714e3-905e-4e20-97c1-043685cae097 | 1 | 2024-06-10 |
| 17856-1127-2 | ML - Milliliter | 17856-1127 | 66cf67fe-098b-44ed-af11-ea6e69bd17a7 | 1 | 2024-06-10 |
| 17856-1127-3 | ML - Milliliter | 17856-1127 | e067a394-8c02-4ce9-a6a7-be9ca07d796c | 1 | 2024-06-10 |
| 17856-1127-4 | ML - Milliliter | 17856-1127 | c419747c-7cee-4a84-a0ab-0b787a395329 | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOCUSATE SODIUM, EXTRA STRENGTH 250 MG | DOCUSATE SODIUM | Advanced Rx LLC | fc8cf24e-8ca1-b3fb-e053-6294a90a7a50 | 2026-07-06 | Warnings | M007 |
| Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) | NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) | Reedfresh Co., LTD | 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 | 2026-07-05 | Warnings | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Protective Industrial Products, Inc. | 558e5926-9027-d3f6-e063-6294a90ab121 | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 2000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a1d07e-0006-0c75-e063-6394a90a7acc | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-07-02 | Warnings | 059QF0KO0R |
| Sterile Eyesaline Eyewash | STERILE EYESALINE EYEWASH | Protective Industrial Products, Inc. | 55a290e8-8310-8be4-e063-6394a90abdce | 2026-07-02 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Protective Industrial Products, Inc. | 55a261c2-725d-6765-e063-6294a90a3260 | 2026-07-02 | Warnings | 059QF0KO0R |
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Curewell Docusate Sodium Liquid | DOCUSATE SODIUM.50MG/5ML | RMT HEALTH LLC | 55903043-2a1d-0525-e063-6394a90ae182 | 2026-07-01 | Warnings | M007 |
| Senna | SENNOSIDES 8.6 MG TABLETS | Aarkish Pharmaceuticals NJ Inc. | 564bc9a5-13b5-4cce-a349-6b2e122683ed | 2026-07-01 | Warnings | M007 |
| Senna-S | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | Aarkish Pharmaceuticals NJ Inc. | faca8f3e-d9eb-44c5-93ab-f59ed1c0f56f | 2026-07-01 | Warnings | M007 |
| ENEMEEZ | DOCUSATE SODIUM | Quest Products, LLC | 0b06445d-0839-497e-bdff-e0fe224a7738 | 2026-06-30 | Warnings | M007 |
| ENEMEEZ Plus | DOCUSATE SODIUM AND BENZOCAINE | Quest Products, LLC | 1670ca59-7275-4ac6-bef4-674a7b24c7b3 | 2026-06-30 | Warnings | M007 |
| Mineral oil | MINERAL OIL | CVS Pharmacy, Inc. | 1183bcbc-51ec-e53a-e063-6394a90af0f2 | 2026-06-26 | Warnings, Adverse reactions | M007 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552d9018-cc7d-7e1a-e063-6294a90a3322 | 2026-06-26 | Warnings | M007 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-06-26 | Warnings | M007 |
| Walgreens Gentle Laxative | BISACODYL SUPPOSITORY | Walgreens | 20c43036-830b-0e1d-e063-6394a90adf5f | 2026-06-25 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | American Health Packaging | be7cab51-ce7e-465d-95db-083e69288cfd | 2026-06-25 | Warnings | M007 |
| SET 4TE HOMO | ADEPS SUILLUS, BRYONIA (ALBA), CALCAREA PHOSPHORICA, CHOLINUM, DNA, DOPAMINE (HYDROCHLORIDE), FERRUM PHOSPHORICUM, FOLIC ACID, INSULINUM (HUMAN), LEPTIN, MAGNESIA MURIATICA, L-METHIONINE, METHYLCOBALAMIN, PROTEUS (VULGARIS), RHUS TOX, RIBOFLAVINUM, RUTA GRAVEOLENS, SACCHARUM OFFICINALE, THIOSINAMINUM, ZINCUM METALLICUM | Deseret Biologicals, Inc. | e7b8d75b-f2bc-4013-91e7-bf5bbec11a90 | 2026-06-25 | Warnings | C151H8M554 |
| Epsom Salt | MAGNESIUM SULFATE | Vi-Jon, LLC | ba490c22-19f0-4887-9509-bd3d32e0f5b1 | 2026-06-24 | Warnings, Adverse reactions | M007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.